Trgovina DiaMedica Therapeutics Inc. - DMAC CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.1100 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 1.5458 |
Odpri* | 1.545 |
Enoletna sprememba* | -41.7% |
Dnevni razpon* | 1.545 - 1.575 |
Razpon 52 wk | 1.12-3.06 |
Povprečni obseg (10 dni) | 26.19K |
Povprečni obseg (3 meseci) | 827.55K |
Tržna kapitalizacija | 45.48M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 26.44M |
Prihodki | N/A |
EPS | -0.50 |
Dividenda (donosnost v %) | N/A |
Beta | 1.76 |
Datum naslednjega zaslužka | Mar 28, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 1.5458 | -0.0479 | -3.01% | 1.5937 | 1.6633 | 1.5454 |
Mar 21, 2023 | 1.6729 | -0.0391 | -2.28% | 1.7120 | 1.7122 | 1.5843 |
Mar 20, 2023 | 1.6925 | -0.0382 | -2.21% | 1.7307 | 1.7314 | 1.6529 |
Mar 17, 2023 | 1.7316 | -0.0188 | -1.07% | 1.7504 | 1.7505 | 1.7010 |
Mar 16, 2023 | 1.8296 | 0.0891 | 5.12% | 1.7405 | 1.8394 | 1.7405 |
Mar 15, 2023 | 1.6923 | -0.0383 | -2.21% | 1.7306 | 1.7416 | 1.6820 |
Mar 14, 2023 | 1.7805 | 0.0878 | 5.19% | 1.6927 | 1.8297 | 1.6422 |
Mar 13, 2023 | 1.6922 | 0.1276 | 8.16% | 1.5646 | 1.7221 | 1.5646 |
Mar 10, 2023 | 1.6531 | -0.0182 | -1.09% | 1.6713 | 1.7019 | 1.5645 |
Mar 9, 2023 | 1.6923 | 0.0502 | 3.06% | 1.6421 | 1.7707 | 1.6421 |
Mar 8, 2023 | 1.7709 | 0.0994 | 5.95% | 1.6715 | 1.7906 | 1.6715 |
Mar 7, 2023 | 1.7219 | 0.0798 | 4.86% | 1.6421 | 1.7221 | 1.6421 |
Mar 6, 2023 | 1.7020 | -0.0188 | -1.09% | 1.7208 | 1.7612 | 1.6723 |
Mar 3, 2023 | 1.7316 | 0.0790 | 4.78% | 1.6526 | 1.7514 | 1.6526 |
Mar 2, 2023 | 1.7414 | 0.0300 | 1.75% | 1.7114 | 1.7612 | 1.7114 |
Mar 1, 2023 | 1.7315 | -0.0294 | -1.67% | 1.7609 | 1.7609 | 1.6428 |
Feb 28, 2023 | 1.6923 | 0.0502 | 3.06% | 1.6421 | 1.7416 | 1.6421 |
Feb 27, 2023 | 1.6535 | 0.0099 | 0.60% | 1.6436 | 1.7024 | 1.5842 |
Feb 24, 2023 | 1.6729 | 0.0297 | 1.81% | 1.6432 | 1.6828 | 1.6333 |
Feb 23, 2023 | 1.6925 | -0.0089 | -0.52% | 1.7014 | 1.7604 | 1.6822 |
DiaMedica Therapeutics Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0.5 | 0 |
Celotni odhodki iz poslovanja | 13.646 | 12.699 | 11.593 | 7.261 | 4.519 |
Celotna prodaja/splošni/upravni stroški Odhodki | 4.881 | 4.389 | 3.693 | 2.739 | 1.313 |
Raziskave in razvoj | 8.765 | 8.31 | 7.9 | 4.522 | 3.206 |
Depreciation / Amortization | |||||
Prihodki iz poslovanja | -13.646 | -12.699 | -11.593 | -6.761 | -4.519 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0 | -0.039 | 0.009 | ||
Drugo, neto | 0.082 | 0.434 | 0.975 | 1.146 | 0.25 |
Čisti dobiček pred obdavčitvijo | -13.564 | -12.265 | -10.618 | -5.654 | -4.26 |
Čisti dobiček po davkih | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Čisti dobiček pred dodatnimi postavkami | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Čisti dobiček | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Popravljen čisti dobiček | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Popravljene ponderirane povprečne delnice | 20.7734 | 15.6803 | 11.9877 | 7.74352 | 5.93579 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.6543 | -0.78391 | -0.88833 | -0.74049 | -0.71768 |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.6543 | -0.78391 | -0.88833 | -0.74049 | -0.71768 |
Prihodki | 0 | 0.5 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 3.536 | 3.246 | 3.416 | 3.365 | 3.619 |
Celotna prodaja/splošni/upravni stroški Odhodki | 1.562 | 1.375 | 1.084 | 1.209 | 1.213 |
Raziskave in razvoj | 1.974 | 1.871 | 2.332 | 2.156 | 2.406 |
Prihodki iz poslovanja | -3.536 | -3.246 | -3.416 | -3.365 | -3.619 |
Drugo, neto | 0.035 | 0.007 | -0.027 | 0.098 | 0.004 |
Čisti dobiček pred obdavčitvijo | -3.501 | -3.239 | -3.443 | -3.267 | -3.615 |
Čisti dobiček po davkih | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Čisti dobiček pred dodatnimi postavkami | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Čisti dobiček | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Popravljen čisti dobiček | -3.508 | -3.246 | -3.45 | -3.274 | -3.622 |
Popravljene ponderirane povprečne delnice | 26.4431 | 26.5021 | 19.0357 | 18.7862 | 18.7667 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.13266 | -0.12248 | -0.18124 | -0.17428 | -0.193 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.13266 | -0.12248 | -0.18124 | -0.17428 | -0.193 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 45.439 | 27.921 | 8.836 | 17.972 | 1.494 |
Denarna sredstva in kratkoročne naložbe | 45.112 | 27.507 | 7.878 | 16.823 | 1.353 |
Cash | 4.707 | 7.409 | 3.883 | 16.823 | 1.353 |
Celotne terjatve, neto | 0.13 | 0.34 | 0.823 | 0.78 | 0.08 |
Prepaid Expenses | 0.084 | 0.064 | 0.047 | 0.369 | 0.061 |
Total Assets | 45.551 | 28.095 | 9.053 | 18.339 | 1.802 |
Property/Plant/Equipment, Total - Net | 0.112 | 0.174 | 0.217 | 0.096 | 0.037 |
Property/Plant/Equipment, Total - Gross | 0.179 | 0.231 | 0.26 | ||
Accumulated Depreciation, Total | -0.067 | -0.057 | -0.043 | ||
Total Current Liabilities | 1.524 | 2.028 | 1.318 | 1.296 | 1.003 |
Accounts Payable | 0.509 | 1.099 | 0.182 | ||
Accrued Expenses | 1.011 | 0.923 | 1.13 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.084 | |||
Total Liabilities | 1.527 | 2.081 | 1.436 | 1.314 | 1.003 |
Total Long Term Debt | 0.003 | 0.007 | 0.013 | 0.018 | 0 |
Other Liabilities, Total | 0 | 0.046 | 0.105 | ||
Total Equity | 44.024 | 26.014 | 7.617 | 17.025 | 0.799 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 126.576 | 94.925 | 64.232 | 62.993 | 41.033 |
Retained Earnings (Accumulated Deficit) | -82.501 | -68.909 | -56.617 | -45.968 | -40.234 |
Other Equity, Total | -0.051 | -0.002 | 0.002 | ||
Total Liabilities & Shareholders’ Equity | 45.551 | 28.095 | 9.053 | 18.339 | 1.802 |
Total Common Shares Outstanding | 26.4431 | 18.7462 | 12.0069 | 11.9569 | 6.37066 |
Accounts Receivable - Trade, Net | 0.13 | 0.78 | 0.08 | ||
Other Long Term Assets, Total | 0 | 0.271 | 0.271 | ||
Payable/Accrued | 1.291 | 0.919 | |||
Current Port. of LT Debt/Capital Leases | 0.004 | 0.006 | 0.006 | 0.005 | 0 |
Capital Lease Obligations | 0.003 | 0.007 | 0.013 | 0.018 | 0 |
Kratkoročne naložbe | 40.405 | 20.098 | 3.995 | ||
Other Current Assets, Total | 0.113 | 0.01 | 0.088 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 42.111 | 45.439 | 48.537 | 21.629 | 24.195 |
Denarna sredstva in kratkoročne naložbe | 41.047 | 45.112 | 48.097 | 21.295 | 23.401 |
Cash | 3.032 | 4.707 | 16.219 | 2.228 | 3.329 |
Kratkoročne naložbe | 38.015 | 40.405 | 31.878 | 19.067 | 20.072 |
Celotne terjatve, neto | 0.168 | 0.13 | 0.104 | 0.016 | 0.337 |
Prepaid Expenses | 0.793 | 0.084 | 0.336 | 0.318 | 0.457 |
Total Assets | 42.211 | 45.551 | 48.664 | 21.774 | 24.356 |
Property/Plant/Equipment, Total - Net | 0.1 | 0.112 | 0.127 | 0.145 | 0.161 |
Property/Plant/Equipment, Total - Gross | 0.162 | 0.179 | 0.187 | 0.199 | 0.209 |
Accumulated Depreciation, Total | -0.062 | -0.067 | -0.06 | -0.054 | -0.048 |
Total Current Liabilities | 1.434 | 1.524 | 1.624 | 1.44 | 1.178 |
Accounts Payable | 0.433 | 0.509 | 0.699 | 0.239 | 0.689 |
Accrued Expenses | 0.995 | 1.011 | 0.921 | 1.196 | 0.483 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.006 | 0.004 | 0.004 | 0.005 | 0.006 |
Total Liabilities | 1.443 | 1.527 | 1.628 | 1.456 | 1.211 |
Total Long Term Debt | 0.009 | 0.003 | 0.004 | 0.005 | 0.005 |
Capital Lease Obligations | 0.009 | 0.003 | 0.004 | 0.005 | 0.005 |
Other Liabilities, Total | 0 | 0 | 0.011 | 0.028 | |
Total Equity | 40.768 | 44.024 | 47.036 | 20.318 | 23.145 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 126.884 | 126.576 | 126.296 | 96.126 | 95.68 |
Retained Earnings (Accumulated Deficit) | -86.009 | -82.501 | -79.255 | -75.805 | -72.531 |
Other Equity, Total | -0.107 | -0.051 | -0.005 | -0.003 | -0.004 |
Total Liabilities & Shareholders’ Equity | 42.211 | 45.551 | 48.664 | 21.774 | 24.356 |
Total Common Shares Outstanding | 26.4431 | 26.4431 | 26.4392 | 18.7862 | 18.7862 |
Accounts Receivable - Trade, Net | 0.166 | 0.13 | |||
Other Current Assets, Total | 0.103 | 0.113 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 |
Denarna sredstva iz poslovanja | -12.252 | -9.185 | -9.102 | -5.696 | -3.9 |
Denarna sredstva iz poslovanja | 0.024 | 0.021 | 0.021 | 0.015 | 0.004 |
Nedenarne postavke | 1.777 | 1.891 | 1.139 | 0.659 | 0.4 |
Denarna sredstva Plačane obresti | 0.002 | 0.002 | |||
Spremembe v obratnem kapitalu | -0.461 | 1.195 | 0.387 | -0.636 | -0.044 |
Denarna sredstva pri naložbenju | -20.537 | -16.134 | -3.908 | -0.05 | -0.022 |
Kapitalski izdatki | -0.022 | -0.047 | -0.002 | -0.05 | -0.022 |
Denarna sredstva pri financiranju | 30.087 | 28.845 | 0.07 | 21.216 | 3.539 |
Izdaja (odplačilo) delnic, neto | 30.093 | 28.85 | 0.075 | 21.216 | 3.539 |
Učinki deviznih tečajev | |||||
Neto sprememba denarnih sredstev | -2.702 | 3.526 | -12.94 | 15.47 | -0.383 |
Cash Taxes Paid | 0.028 | 0.036 | 0.026 | ||
Celotne druge postavke denarnih tokov pri naložbenju | -20.515 | -16.087 | -3.906 | ||
Izdaja (odplačilo) dolga, neto | -0.006 | -0.005 | -0.005 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.508 | -13.592 | -10.346 | -6.896 | -3.622 |
Cash From Operating Activities | -3.888 | -12.252 | -9.448 | -6.402 | -4.313 |
Cash From Operating Activities | 0.006 | 0.024 | 0.018 | 0.012 | 0.006 |
Non-Cash Items | 0.443 | 1.777 | 1.354 | 1.023 | 0.551 |
Changes in Working Capital | -0.829 | -0.461 | -0.474 | -0.541 | -1.248 |
Cash From Investing Activities | 2.214 | -20.537 | -11.848 | 0.98 | -0.009 |
Capital Expenditures | 0 | -0.022 | -0.015 | -0.013 | -0.009 |
Other Investing Cash Flow Items, Total | 2.214 | -20.515 | -11.833 | 0.993 | 0 |
Cash From Financing Activities | -0.001 | 30.087 | 30.106 | 0.241 | 0.242 |
Issuance (Retirement) of Stock, Net | 0 | 30.093 | 30.111 | 0.244 | 0.244 |
Issuance (Retirement) of Debt, Net | -0.001 | -0.006 | -0.005 | -0.003 | -0.002 |
Net Change in Cash | -1.675 | -2.702 | 8.81 | -5.181 | -4.08 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
EQT Partners AB | Private Equity | 10.8 | 2855847 | 304827 | 2022-07-08 | LOW |
Trill AB,LLC. | Corporation | 9.6472 | 2551020 | 2551020 | 2021-09-28 | |
Jacinto (Richard II) | Individual Investor | 9.4543 | 2500000 | 850947 | 2022-12-31 | LOW |
Lytton (Laurence W) | Individual Investor | 4.0539 | 1071970 | -308296 | 2021-12-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.961 | 782989 | 349 | 2022-12-31 | LOW |
Giuffre (Randall Michael) | Individual Investor | 1.4983 | 396184 | 35130 | 2023-01-03 | LOW |
Omega Advisors, Inc. | Investment Advisor | 1.1345 | 300000 | 100000 | 2021-12-31 | LOW |
Jacob Asset Management of New York, LLC | Investment Advisor | 0.8839 | 233730 | -4770 | 2022-12-31 | LOW |
Pilnik (Richard D) | Individual Investor | 0.7937 | 209882 | 55555 | 2023-01-03 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6991 | 184870 | -349 | 2022-12-31 | LOW |
Lynch (Timothy Patrick) | Individual Investor | 0.3792 | 100259 | -100000 | 2022-12-31 | LOW |
Burroughs (Amy Louise) | Individual Investor | 0.2772 | 73288 | 17156 | 2023-01-03 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.2723 | 72012 | 2814 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.252 | 66629 | 0 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2496 | 65997 | 1067 | 2022-12-31 | LOW |
Pauls (Dietrich John) | Individual Investor | 0.211 | 55804 | 20000 | 2022-11-16 | |
Morgan Stanley & Co. LLC | Research Firm | 0.1672 | 44201 | 2194 | 2022-12-31 | MED |
Alcorn Harry W Jr | Individual Investor | 0.1663 | 43981 | 399 | 2022-03-22 | MED |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.1612 | 42634 | 0 | 2022-12-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.1483 | 39216 | 4304 | 2022-12-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
DiaMedica Therapeutics Inc. Company profile
O družbi DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. je biofarmacevtsko podjetje v klinični fazi. Podjetje se osredotoča na razvoj zdravil za nevrološke in ledvične bolezni, kot sta akutna ishemična možganska kap (AIS) in kronična ledvična bolezen (CKD). Vodilni izdelek družbe DM199 posnema obnašanje naravno prisotnih človeških beljakovin KLK1, da bi ohranil in obnovil prekrvavitev tkiva, poškodovanega zaradi kapi, ter izboljšal splošno delovanje ledvic. KLK1 je serinska proteaza ali beljakovina, ki se proizvaja predvsem v ledvicah, trebušni slinavki in žlezah slinavkah. Terapija z DM199 lahko izboljša cirkulacijo in splošno delovanje kritičnih sistemov ter zmanjša vnetje in oksidativni stres. Družba pripravlja tudi druge izdelke za nefropatijo IgA in afriške Američane s CKD.
Industry: | Bio Therapeutic Drugs |
301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com